A. Anemona

发表

Myopia in secondary school students in Mwanza City, Tanzania: the need for a national screening programme

R. Balira, A. Foster, J. Todd, 2002, The British journal of ophthalmology.

Safety, Immunogenicity and Dose Ranging of a New Vi-CRM197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults

P. van Damme, E. Marchetti, A. Podda, 2011, PloS one.

A Randomized Trial to Determine the Tolerability and Immunogenicity of a Quadrivalent Meningococcal Glycoconjugate Vaccine in Healthy Adolescents

K. Reisinger, R. Jacobson, L. Jackson, 2009, The Pediatric infectious disease journal.

Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlers

S. Halperin, F. Diaz-Mitoma, P. Dull, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.

P. Dull, A. Anemona, U. Grunwald, 2010, Vaccine.

Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents

C. Gill, R. Baxter, P. Dull, 2010, Human vaccines.

Variations of HIV and STI prevalences within communities neighbouring new goldmines in Tanzania: importance for intervention design

D. Watson-Jones, J. Changalucha, D. Ross, 2003, Sexually transmitted infections.

Bordetella parapertussis Infection in Children: Epidemiology, Clinical Symptoms, and Molecular Characteristics of Isolates

M. L. Ciofi Degli Atti, A. Tozzi, P. Mastrantonio, 1998, Journal of Clinical Microbiology.

Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a community-randomized trial

R. Hayes, H. Weiss, J. Changalucha, 2007, AIDS.

Randomized Trial on the Safety, Tolerability, and Immunogenicity of MenACWY-CRM, an Investigational Quadrivalent Meningococcal Glycoconjugate Vaccine, Administered Concomitantly with a Combined Tetanus, Reduced Diphtheria, and Acellular Pertussis Vaccine in Adolescents and Young Adults

R. Gasparini, G. Gabutti, P. Dull, 2010, Clinical and Vaccine Immunology.

Acceptability of azithromycin for the control of trachoma in Northern Tanzania.

D. Mabey, A. Solomon, P. Massae, 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines.

S. Salmaso, M. L. Ciofi Degli Atti, A. Tozzi, 2001, Pediatrics.

“A bit more truthful”: the validity of adolescent sexual behaviour data collected in rural northern Tanzania using five methods

R. Hayes, D. Wight, G. Mshana, 2004, Sexually Transmitted Infections.

Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source.

S. Ram, L. DeTora, J. Welsch, 2011, Vaccine.

Antigen presentation by Follicular Dendritic cells to cognate B cells is pivotal for Generalised Modules for membrane antigens (GMMA) immunogenicity.

E. Bartolini, F. Necchi, D. Piccioli, 2022, Vaccine.

Case definitions.

S. Salmaso, A. Anemona, P. Dal Lago, 1997, Developments in biological standardization.

Effect of aluminum adjuvants on safety and immunogenicity of Haemophilus influenzae type b‐CRM197 conjugate vaccine

A. Kara, E. Marchetti, G. Kanra, 2003, Pediatrics international : official journal of the Japan Pediatric Society.

Incidence of invasive Haemophilus influenzae type b disease in Italian children

S. Salmaso, A. Tozzi, S. Wassilak, 2004, European Journal of Epidemiology.

Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants

J. Langley, K. Ford, Ly-Mee Yu, 2009, The Pediatric infectious disease journal.

HIV Prevalence and Frequency of Risk Behavior in Injecting Drug Users Entering Treatment and Out of Treatment: A Cross-Sectional Study in Five Italian Cities

S. Salmaso, C. Perucci, G. Rezza, 1994 .

A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.

D Greco, D. L. Klein, W C Blackwelder, 1996, The New England journal of medicine.

Repeat whole cell vaccinations should be avoided after hypotonic-hyporesponsive episodes

S. Salmaso, M. L. Ciofi Degli Atti, A. Tozzi, 1998, BMJ.

Predictors of adverse events after the administration of acellular and whole-cell diphtheria-tetanus-pertussis vaccines.

S. Salmaso, M. L. Ciofi Degli Atti, A. Tozzi, 1998, Vaccine.

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

J. Langley, K. Ford, Ly-Mee Yu, 2008, JAMA.

Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review

Vincent Muturi-Kioi, G. Leroux-Roels, A. Podda, 2016, PloS one.

Low specificity of the Murex fourth‐generation HIV enzyme immunoassay in Tanzanian adolescents

R. Hayes, D. Watson-Jones, J. Parry, 2007, Tropical medicine & international health : TM & IH.

Asking semi‐literate adolescents about sexual behaviour: the validity of assisted self‐completion questionnaire (ASCQ) data in rural Tanzania

R. Hayes, D. Wight, A. Obasi, 2004, Tropical medicine & international health : TM & IH.

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.

Z. Bhutta, S. Juvekar, E. Marchetti, 2014, The Lancet. Infectious diseases.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

S. Salmaso, M. L. Ciofi Degli Atti, A. Tozzi, 2001, Pediatrics.

Pertussis Vaccines Administered in Infancy : The Italian Experience Sustained Efficacy During the First 6 Years of Life of 3-Component Acellular

A. Tozzi, P. Mastrantonio, A. Anemona, 2001 .

Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe

O. Finco, E. Marchetti, A. Podda, 2017, EBioMedicine.

Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group.

S. Salmaso, M. L. Ciofi Degli Atti, A. Tozzi, 1998, Vaccine.

Sample size for equivalence trials: A case study from a vaccine lot consistency trial

J. Ganju, A. Izu, A. Anemona, 2008, Statistics in medicine.

The seroepidemiology of measles in Western Europe

France, Finland., J. Schellekens, 2001, Epidemiology and Infection.

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

J. Langley, K. Ford, Ly-Mee Yu, 2008, JAMA.

ImmunogenicityofaTetravalentMeningococcal Glycoconjugate Vaccine in Infants

J. Langley, K. Ford, A. Pollard, 2006 .